Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke

Am J Cardiol. 2007 Mar 27;99(6C):1E-35E. doi: 10.1016/j.amjcard.2007.02.001. Epub 2007 Mar 5.
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Antihypertensive Agents / therapeutic use*
  • Cardiovascular Diseases / drug therapy*
  • Clinical Trials as Topic
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / metabolism
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Mineralocorticoid Receptor Antagonists
  • Smoking Cessation*
  • Stroke / drug therapy*

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Mineralocorticoid Receptor Antagonists